Incanthera Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Incanthera Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11335
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Incanthera Ltd (Incanthera) is a drug development and targeted cancer medicines company that discovers and develops novel treatments for solid tumours. The company’s pipeline drug candidates include ICT01-2588, a vascular disrupting agent, based on the tumor-blasting technology; ICT03 – Es5, a potent bioreductive anticancer agent, which are targeted at destroying all forms of solid tumors; ICT04-CYP, that target on colorectal cancer. Incanthera assists the commercialization of the drug development and licensing these to large pharmaceutical companies. The company provides technology and products in the field of oncology and diagnostics. It operates research laboratory in Bradford, West Yorkshire. Incanthera is headquartered in Manchester, the UK.

Incanthera Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Incanthera Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Incanthera Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Incanthera Acquires Drug Development Programme from University of Bradford 10
Venture Financing 11
Incanthera Raises USD2 Million in Financing Round 11
Incanthera Raises US$1 Million In Venture Financing 12
Incanthera Raises US$0.6 Million In Venture Financing 13
Partnerships 14
ImmuPharma to Enter into Partnership with Incanthera 14
Licensing Agreements 15
Incanthera Enters into Licensing Agreement for ICT01-2588 15
Acquisition 16
Incanthera Acquires Spear Therapeutics 16
Incanthera Acquires Onco-NX, Drug Discovery Company 17
Incanthera Ltd – Key Competitors 18
Incanthera Ltd – Key Employees 19
Incanthera Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Incanthera Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Incanthera Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Incanthera Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Incanthera Acquires Drug Development Programme from University of Bradford 10
Incanthera Raises USD2 Million in Financing Round 11
Incanthera Raises US$1 Million In Venture Financing 12
Incanthera Raises US$0.6 Million In Venture Financing 13
ImmuPharma to Enter into Partnership with Incanthera 14
Incanthera Enters into Licensing Agreement for ICT01-2588 15
Incanthera Acquires Spear Therapeutics 16
Incanthera Acquires Onco-NX, Drug Discovery Company 17
Incanthera Ltd, Key Competitors 18
Incanthera Ltd, Key Employees 19
Incanthera Ltd, Other Locations 20
Incanthera Ltd, Subsidiaries 20

List of Figures
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Incanthera Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oncodesign SA (ALONC):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncodesign SA (Oncodesign) is a biopharmaceutical company, specializing in precision medicine offers drug discovery and pharmacological evaluation services for cancer. Its service offerings include integrated drug discovery; metabolic and pharmacokinetic characteristics of chemical and biolo …
  • Sujana Universal Industries Ltd. (SUJANAUNI):企業の財務・戦略的SWOT分析
    Sujana Universal Industries Ltd. (SUJANAUNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Taconic Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Taconic Biosciences Inc (Taconic), formerly Taconic Farms Inc is a research model provider that offers animal health models and laboratory services. The company’s products include taconic transgenic mouse models, emerging models, cryopreserved models, traditional models, diet induced obese, …
  • Arkady Novikov Restaurant Group:企業の戦略・SWOT・財務分析
    Arkady Novikov Restaurant Group - Strategy, SWOT and Corporate Finance Report Summary Arkady Novikov Restaurant Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Nano-Terra Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nano-Terra Inc (Nano-Terra) is a clean technology company that develops and commercializes nano technology products. The company’s products include coating, advanced materials, organic and inorganic molecules, materials, polymers and UV water filtration system. It provides surface science, c …
  • S-Oil Corporation Inc (010950):企業の財務・戦略的SWOT分析
    S-Oil Corporation Inc (010950) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Callidus Software Inc (CALD):企業の財務・戦略的SWOT分析
    Summary Callidus Software Inc (Callidus) a subsidiary of SAP SE, operates as a technology company that offers a cloud-based customer relationship management (CRM) solutions. The company’s product portfolio includes contract life cycle management (CLM), configure price quote (CPQ) solutions, clicktoo …
  • Sienna Biopharmaceuticals Inc (SNNA)-医療機器分野:企業M&A・提携分析
    Summary Sienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a biopharmaceutical company that develops innovation therapies for inflammatory skin conditions and aesthetic conditions. It offers topical by design or low systemic exposure technology platform for local treatment Photoparticle th …
  • Trican Well Service Ltd (TCW):石油・ガス:M&Aディール及び事業提携情報
    Summary Trican Well Service Ltd (Trican) is an oilfield services company, which provides specialized products, equipment, services and technology for use in the drilling, completion, stimulation and reworking of oil and gas wells. Its specialized services comprise fracturing, cementing, coiled tubin …
  • Cellectar Biosciences Inc (CLRB):企業の財務・戦略的SWOT分析
    Cellectar Biosciences Inc (CLRB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • EP Petroecuador:企業の戦略的SWOT分析
    EP Petroecuador - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Robert Half International Inc.:企業の戦略・SWOT・財務情報
    Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report Summary Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Royal DSM NV (DSM):企業の財務・戦略的SWOT分析
    Royal DSM NV (DSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Interfor Corp:企業の戦略・SWOT・財務情報
    Interfor Corp - Strategy, SWOT and Corporate Finance Report Summary Interfor Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cinkarna Celje d.d. Celje (CICG):企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Mah Sing Group Berhad:企業の戦略・SWOT・財務情報
    Mah Sing Group Berhad - Strategy, SWOT and Corporate Finance Report Summary Mah Sing Group Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Lechwerke AG (LEC):企業の財務・戦略的SWOT分析
    Summary Lechwerke AG (LechWerke), a subsidiary of Innogy SE is a utility service provider that offers electricity products natural gas products and energy services. The company provides services such as electrical safety, gas safety, energy monitoring, power plant contracting, street lighting, energ …
  • Advanced Electronics Company:企業の戦略・SWOT・財務情報
    Advanced Electronics Company - Strategy, SWOT and Corporate Finance Report Summary Advanced Electronics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lysogene SAS (LYS):製薬・医療:M&Aディール及び事業提携情報
    Summary Lysogene SAS (Lysogene) is a clinical research center that offers basic research and clinical development programs. The center offers clinical development of gene therapy for neurodegenerative disorders such as Parkinson and Alzheimer diseases. It also develops models in gene therapy trials …
  • Emergent BioSolutions Inc (EBS):製薬・医療:M&Aディール及び事業提携情報
    Summary Emergent BioSolutions Inc (Emergent) is a life sciences company. It focuses on protecting and enhancing life by providing specialized products to governments and healthcare providers. The company develops specialty products targeting public health threats and emerging infectious diseases. It …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆